Prognostic Value of Gut Microbe-Generated Metabolite Phenylacetylglutamine in Patients with Heart Failure
W.H. Wilson Tang(Cleveland Clinic), Stanley L. Hazen(Cleveland Clinic), Arash Haghikia(German Centre for Cardiovascular Research), Elisabeth Steinhagen‐Thiessen(Charité - Universitätsmedizin Berlin), Ina Nemet(Cleveland Clinic Lerner College of Medicine), Fredrik Bäckhed(Sahlgrenska University Hospital), Xinmin S. Li(Cleveland Clinic), Michael A. Fischbach(Stanford University), Robert Koeth(Cleveland Clinic), Arjun Deb(Nanosys (United States)), Maximilian König(Charité - Universitätsmedizin Berlin), Ilja Demuth(Charité - Universitätsmedizin Berlin), Marco Witkowski(Cleveland Clinic), Ulf Landmesser(Deutsches Herzzentrum der Charité), Yuping Wu(Cleveland State University)
Cited by 38
Related Papers
Obesity alters gut microbial ecology
|Proceedings of the National Academy of Sciences|2005|6.1k
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k